EPHA2 and urinary bladder cancer: As recently shown, progranulin is highly expressed in bladder cancer cells and is the prevalent ligand for EphA2, thereby constituting an oncogenic pathway driving motility, invasion, and in vivo tumor formation of bladder cancer cells [35,48].